section name header

Basics ⬇

DESCRIPTION

EPIDEMIOLOGY

Prevalence

Prevalence variable, depends on underlying structural heart disease, and increases with increasing age.

RISK FACTORS

Structural heart disease

ETIOLOGY

COMMONLY ASSOCIATED CONDITIONS

Structural heart disease

Diagnosis ⬆ ⬇

Signs and symptoms:

DIAGNOSTIC TESTS & INTERPRETATION

Lab

Generally not applicable; drug level measurement (especially digitalis) is indicated if toxicity suspected.

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

No drugs directly enhance AV conduction. If digitalis is toxic, Digibind antibody is indicated to inhibit digitalis effect on the heart.

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

SURGERY

IN-PATIENT CONSIDERATIONS

Admission Criteria

If a patient has symptomatic AV block (especially 3rd-degree or 2:1 AV block with a wide QRS), admission is warranted, usually for pacemaker implantation or treatment of drug toxicity.

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

DIET

No specific diet

PATIENT EDUCATION

PROGNOSIS

COMPLICATIONS

Complications due to the AV block itself or to its treatment include syncope, injury, and occasionally death.

Miscellaneous ⬆ ⬇

CODES

ICD9

SNOMED

Reference(s) ⬆ ⬇

ADDITIONAL READING

Author(s) ⬆

Peter Ott